My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 171

    1.

    The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.

    Stumvoll M, Häring H.

    Diabetes. 2002 Aug;51(8):2341-7. Review.PMID: 12145143 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.

    Stefan N, Fritsche A, Häring H, Stumvoll M.

    Diabetes. 2001 May;50(5):1143-8.PMID: 11334419 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity.

    Stumvoll M, Wahl HG, Löblein K, Becker R, Machicao F, Jacob S, Häring H.

    Diabetes. 2001 Apr;50(4):876-81.PMID: 11289055 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.

    Eriksson JG, Lindi V, Uusitupa M, Forsén TJ, Laakso M, Osmond C, Barker DJ.

    Diabetes. 2002 Jul;51(7):2321-4.PMID: 12086968 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.

    Tönjes A, Stumvoll M.

    Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):410-4. Review.PMID: 17563457 [PubMed - indexed for MEDLINE]Related articles

    9.

    A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.

    Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9.PMID: 15739197 [PubMed - indexed for MEDLINE]Related articles

    10.

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.

    Lee BC, Lee HJ, Chung JH.

    Neurosci Lett. 2006 Dec 20;410(2):141-5. Epub 2006 Nov 3.PMID: 17084528 [PubMed - indexed for MEDLINE]Related articles

    11.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G.

    Clin Endocrinol (Oxf). 2002 Oct;57(4):481-6.PMID: 12354130 [PubMed - indexed for MEDLINE]Related articles

    13.

    Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.

    Stumvoll M, Stefan N, Fritsche A, Madaus A, Tschritter O, Koch M, Machicao F, Häring H.

    J Mol Med. 2002 Jan;80(1):33-8. Epub 2001 Sep 15.PMID: 11862322 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity]

    Fritsche A, Madaus A, Tschritter O, Ozeker M, Wulle EL, Machicao F, Häring H, Stumvoll M.

    Dtsch Med Wochenschr. 2001 May 18;126(20):580-4. German. PMID: 11402923 [PubMed - indexed for MEDLINE]Related articles

    15.

    Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

    Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ.

    Metabolism. 2004 Jan;53(1):11-6.PMID: 14681835 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.

    Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, Ghaemi A, Sadeghi S, Mirkhani F, Molapour A, Adeli K.

    Clin Chem Lab Med. 2007;45(4):477-82.PMID: 17439324 [PubMed - indexed for MEDLINE]Related articles

    17.

    The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.

    Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C, Kadowaki T.

    Biochem Biophys Res Commun. 2000 Apr 29;271(1):212-6.PMID: 10777704 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P.

    Int J Obes Relat Metab Disord. 2000 Feb;24(2):195-9.PMID: 10702770 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.

    Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A.

    Exp Clin Endocrinol Diabetes. 2002 Apr;110(2):60-6.PMID: 11928067 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity